Loading data for BHC — first visit, this takes a few seconds.
Bausch Health Companies Inc. (BHC)
NYSE: BHC
· Real-Time Price · USD
6.83
+0.36 (5.56%)
At close: Sep 01, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Bausch Health Companies Inc. (BHC) Stock Price, Analysis & Data
No data available
| Bid | 6.65 |
| Market Cap | 2.42B |
| Revenue (ttm) | 10.9B |
| Net Income (ttm) | -1.1B |
| 0.38 | |
| -2.99 | |
| n/a | |
| 1.54 | |
| P/B (ttm) | -1.37 |
| P/S (ttm) | 0.22 |
| Earnings Date | Oct 28, 2026 |
| Ask | 6.88 |
| Volume | 7,631,924 |
| Avg. Volume (20D) | 3,508,446 |
| Open | 6.56 |
| Previous Close | 6.47 |
| Day's Range | 6.54 - 6.87 |
| 52-Week Range | 4.33 - 8.00 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | Nov 10, 2010 |
About BHC
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter prod...
Sector Healthcare
IPO Date Mar 29, 1994
Employees 20,300
Stock Exchange NYSE
Ticker Symbol BHC
Website https://www.bauschhealth.com
Financial Performance
In 2025, Bausch Health Companies's revenue was 10.27B, an increase of 6.66% compared to the previous year's 9.63B. Earnings were 157M, a decrease of -441.3%.
Financial StatementsEarnings Surprise
Bausch Health Companies has released their quarterly earnings on Jul 29, 2026:
- Revenue of $2.85B misses estimates by $0, with 12.73% YoY growth.
- EPS of 1.26 exceeds estimates by 0.25, with 38.46% YoY growth.
Bausch Health Companies Inc. is scheduled to release its earnings on Oct 28, 2026, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2